PABCX
Price
$19.73
Change
+$0.05 (+0.25%)
Updated
Dec 3 closing price
Net Assets
1.06B
RLBEX
Price
$39.78
Change
+$0.11 (+0.28%)
Updated
Dec 3 closing price
Net Assets
269.37B
Interact to see
Advertisement

PABCX vs RLBEX

Header iconPABCX vs RLBEX Comparison
Open Charts PABCX vs RLBEXBanner chart's image
PGIM Balanced C
Price$19.73
Change+$0.05 (+0.25%)
VolumeN/A
Net Assets1.06B
American Funds American Balanced R4
Price$39.78
Change+$0.11 (+0.28%)
VolumeN/A
Net Assets269.37B
PABCX vs RLBEX Comparison Chart in %
View a ticker or compare two or three
VS
PABCX vs. RLBEX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PABCX is a StrongBuy and RLBEX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBEX has more cash in the bank: 269B vs. PABCX (1.06B). RLBEX pays higher dividends than PABCX: RLBEX (1.68) vs PABCX (1.19). PABCX was incepted earlier than RLBEX: PABCX (29 years) vs RLBEX (23 years). PABCX (1.87) is less costly to investors than RLBEX (0.59). PABCX is a more actively managed with annual turnover of: 107.00 vs. RLBEX (44.00). RLBEX has a lower initial minimum investment than PABCX: RLBEX (250) vs PABCX (1000). RLBEX annual gain was more profitable for investors over the last year : 9.28 vs. PABCX (5.05). RLBEX return over 5 years is better than : 39.06 vs. PABCX (20.25).
PABCXRLBEXPABCX / RLBEX
Total Expense Ratio1.810.59307%
Annual Report Gross Expense Ratio1.870.59317%
Fund Existence29 years23 years-
Gain YTD13.41916.57481%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.06B269B0%
Annual Yield % from dividends1.191.6871%
Returns for 1 year5.059.2854%
Returns for 3 years34.1840.1985%
Returns for 5 years20.2539.0652%
Returns for 10 years36.9976.6748%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IPOD10.20N/A
N/A
Dune Acquisition Corp II
MET76.31N/A
N/A
MetLife
PRSU33.90-0.14
-0.40%
Pursuit Attractions and Hospitality Inc
CELC97.49-1.00
-1.01%
Celcuity
GDTC1.74-0.07
-3.87%
CytoMed Therapeutics Limited